The popular French science magazine Sciences et Avenir has published an article explaining the science behind our denovoSkin and denovoCast innovations, and the promise that this brings to patients suffering from severe skin burns and injuries. The journalist had visited CUTISS to see this for herself and to speak with our CEO Daniela and CIO Vincent. “Swiss […]
Sciences et Avenir: A machine produces personalized skin Read More »
PRESS RELEASE Two innovative biotechnology specialists, IBSA Pharma and CUTISS complete license agreement for VitiCell® Agreement grants CUTISS exclusive worldwide license to commercialize VitiCell®. VitiCell® is a CE marked medical device developed by IBSA for the treatment of skin pigmentation disorders. Strategic fit with CUTISS’s expertise in skin tissue bioengineering. Sophia-Antipolis (France) and Zurich (Switzerland), 2
IBSA Pharma and CUTISS complete license agreement for VitiCell Read More »
CUTISS AG
CUTISS HAUS
Grabenstrasse 11
8952 Schlieren, Switzerland
info@cutiss.swiss
Tel. +41 44 244 36 60
© Cutiss AG. All rights reserved.
Would you like to contact us as a journalist?
